Brinker director trades shares under 10b5-1 plan
Brinker International director James C. Katzman reported a small mix of stock grant and sale in company shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Brinker International director James C. Katzman reported a small mix of stock grant and sale in company shares. He received 493 shares of common stock on a grant or award basis at no cost, then sold 547 shares of common stock at $128.11 per share in an open-market transaction. After these transactions, he directly holds 29,355 shares of Brinker International common stock. The filing notes that the reported activity was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by Katzman on June 5, 2025.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 547 | $128.11 | $70K |
| Grant/Award | Common Stock | 493 | $0.00 | $0.00 |
Footnotes (1)
- F1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 5, 2025.
Key Figures
Key Terms
Form 4 regulatory
Rule 10b5-1 trading plan regulatory
open-market sale financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Brinker International (EAT) director James C. Katzman report?
Was the Brinker International (EAT) insider sale made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.